An updated analysis of the eNRGy trial showed that zenocutuzumab may provide meaningful benefit beyond initial disease progression.
Zhaohui Liao Arter, MD
Advertisement
Articles by Zhaohui Liao Arter, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Efficacy and Safety of Immune Checkpoint Inhibitors Combined With Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer
2
Which Head and Neck Cancer Data Should You Watch For at ESMO 2026?
3
EC Expands Enfortumab Vedotin/Pembrolizumab Approval for Resectable MIBC
4
Reducing Stigma and Nihilism Around Lung Cancer Screening and Diagnosis
5